首页> 外文期刊>Journal of immunology research. >Sjogren’s Syndrome and TAM Receptors: A Possible Contribution to Disease Onset
【24h】

Sjogren’s Syndrome and TAM Receptors: A Possible Contribution to Disease Onset

机译:Sjogren的综合征和TAM受体:对疾病发病的可能贡献

获取原文
获取外文期刊封面目录资料

摘要

Sjogren’s syndrome (SS) is a chronic, progressive autoimmune disease featuring both organ-specific and systemic manifestations, the most frequent being dry mouth and dry eyes resulting from lymphocytic infiltration into the salivary and lacrimal glands. Like the related autoimmune disease systemic lupus erythematosus (SLE), SS patients and mouse models display accumulation of apoptotic cells and a Type I interferon (IFN) signature. Receptor tyrosine kinases (RTKs) of the Tyro3, Axl, and Mer (TAM) family are present on the surface of macrophages and dendritic cells and participate in phagocytosis of apoptotic cells (efferocytosis) and inhibition of Type I IFN signaling. This review examines the relationship between TAM receptor dysfunction and SS and explores the potential contributions of TAM defects on macrophages to SS development.
机译:Sjogren的综合征(SS)是一种慢性,渐进的自身免疫疾病,具有机构特异性和系统性表现,最常见的是干燥的口干和干眼症,从淋巴细胞浸润到唾液和泪腺中。与相关的自身免疫疾病全身性红斑狼疮(SLE),SS患者和小鼠模型显示凋亡细胞和I型干扰素(IFN)签名的积累。 Tyro3,AxL和MER(TAM)家族的受体酪氨酸激酶(RTKS)存在于巨噬细胞和树突细胞表面上,并参与凋亡细胞(效力细胞症)的吞噬作用和I型IFN信号传导。本综述研究了TAM受体功能障碍和SS之间的关系,并探讨了TAM对巨噬细胞对SS开发的潜在贡献。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号